ARCHIVES

Advocates Oppose Proposals to Market Drugs After Phase I.

This article is from The Cancer Letter archive.

Vol. 32 No. 22 | June 9, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Cady New SSO President, Rush President Elect; Polockwich, Major Figure In Straus Case, Killed

June 17, 1988

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

Advisors Approve CCOP, EDRN, Pediatric Brain Tumor Network Renewal

March 28, 2003

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

Poll Finds Strong Support For Research; Yarbro Leads International Cancer Nurses.

October 6, 2000

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

December 27, 2002